Search

everythinglearnresearchcommunity

for

Search:↓

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Hypothyroidism may cause certain types of hair loss.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Three specific mutations in the LIPH gene can cause hair loss by damaging the protein's structure and function.

The document's conclusion cannot be provided because the document is not accessible or understandable.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Pigs without the Hairless gene showed skin and thymus changes, useful for studying human hair disorders.

A 72-year-old man was diagnosed with a rare skin form of Rosai-Dorfman disease after years of misdiagnosis.

Different types of stem cells and their environments are key to skin repair and maintenance.

Men with a family history of hair loss are more likely to experience it themselves, especially if both parents have hair loss.

A gene variation is linked to hair thickness in Asians.

Androgens may block hair growth signals, targeting this could treat hair loss.

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

LncRNA MTC boosts growth of goat skin cells, improving cashmere quality.

Targeting colon cancer stem cells might lead to better treatment results.

FPHL affects hair density and diameter, causing visible hair loss in older women.

Finasteride effectively blocks enzyme causing male pattern baldness.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.

DHT, a testosterone byproduct, causes male pattern baldness.

Metformin has limited effectiveness for improving PCOS symptoms and lacks clear benefits, needing more research to confirm its efficacy.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Lymphatic vessels are essential for hair follicle growth and skin regeneration.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Dutasteride helps slow hair loss and boosts hair growth.

Steroidogenic isoenzymes may help improve treatments for common hair loss.